AEGiS-UNAIDS: South Africa AIDS Conference

Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

South Africa AIDS Conference

UNAIDS - June 6, 2007

"If South Africa can achieve its aims, the country will be well on the way to leading Africa into a new phase in the AIDS response," said UNAIDS Executive Director Peter Piot, at the opening of the third South African Aids conference in Durban yesterday.

Congratulating South Africa for its new "ambitious and credible" five-year National Strategic Plan for Aids, which aims to half new infections by 2011, Dr Piot underlined that the effective implementation of the plan is critical for future progress. " The National AIDS Plan represents an incentive for all of us, wherever we work, to take a cold, hard look at what we are doing and to change what needs to change," he said. "Failure to reach the ambitious, but necessary, goals would be a collective failure on all our parts. You have a better chance than any other country in the region to deliver on AIDS. If you can't, who can?" he added.

More than 4000 scientists, activists and medical experts have joined in Durban this week for the third South African AIDS Conference. At the conference opening, Dr Piot joined Deputy President Phumzile Mlambo-Ncguka, who heads the recently restructured South African National AIDS Council, social activist Graca Machel and the Treatment Action Campaign's Nkhensani Mavasa on the podium.

The conference theme is Building Consensus on Prevention, Treatment and Care, and organisers hope to end the four-day meeting with a formal declaration on the way forward on key topics, such as the role of male circumcision in preventing HIV transmission. Other issues up for discussion include WHO/UNAIDS' new guidelines on HIV testing and counselling and the spread of extremely drug resistant tuberculosis, to which people living with HIV are particularly vulnerable.

The conference will run from 5 û 8 June.

070606
UN070603

Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .